Surging Rates Of Pediatric Type 1 Diabetes Amidst COVID-19 Pandemic — Is There A Connection?

The COVID-19 pandemic has impacted almost every aspect of life around the globe, drastically diminishing the state of population health worldwide. One concerning trend that has emerged is a significant increase in children and adolescents diagnosed with type 1 diabetes (T1D) since the start of the pandemic.

Some researchers have hypothesized that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children may heighten the risk of developing type 1 diabetes. However, the scientific landscape is fraught with conflicting evidence, presenting a complex puzzle for investigators to dissect and a pivotal opportunity to explore the root cause of the disease.

Even as numerous studies have documented the rise in pediatric type 1 diabetes cases globally, none have been able to determine the causal link conclusively. While some contend that COVID-19 infection directly elevates the risk of diabetes in children and adolescents, others emphasize the intricate context in which the surging trend has been observed. The extensive list of potential contributing factors underscores the challenge of establishing causation from changes in healthcare utilization, postponed routine visits, and pandemic-related ordinances limiting activities, socialization, and other critical components of childhood development.

Exploring the Evidence: What the Research Shows

“Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis”

Published in JAMA Network Open on June 30, 2023

A recent systematic review and meta-analysis published in JAMA Network Open analyzed data from multiple countries to compare the incidence rates of pediatric diabetes during and before the COVID-19 pandemic.

Data for the analysis was gathered from electronic databases, including Medline, Embase, the Cochrane database, Scopus, and Web of Science, and the grey literature between January 1, 2020, and March 28, 2023, using search terms related to COVID-19, diabetes, and diabetic ketoacidosis (DKA).

The systematic review and meta-analysis comprised 42 studies, collectively involving 102,984 pediatric patients. Their findings unveiled a higher incidence of type 1 diabetes during the COVID-19 pandemic compared to pre-pandemic years.

More specifically, the researchers reported a 14% increase in diabetes incidence during the first year of the pandemic, followed by a 27% rise in the second year compared to pre-pandemic levels. However, the exact reasons underlying these trends remain to be determined.

“Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19”

Published May 22, 2023 in JAMA Network Open 

In a research letter published before the study above, Bavarian scientists presented the results of a large population-based investigation of type 1 diabetes incidence in children who had received a COVID-19 diagnosis since 2020.

Their findings suggest that COVID-19 infection contributed to the observed increase in T1D incidence and that undiagnosed infection — representing the majority of SARS-CoV-2 antibody-positive children — might have contributed to the moderately increased incidence of type 1 diabetes observed in children without a COVID-19 diagnosis.

The study’s authors proposed the initiation of autoimmunity or acceleration of disease progression linked to COVID-19 infection as possible explanations of the connection.

As noted by the researchers, a significant limitation of the study is that it was based on quarterly data, which did not allow them to determine whether T1D was diagnosed before or after COVID-19 infection when both occurred in the same quarter. Furthermore, missing viral confirmation in 70% of the diagnosed children, insufficient numbers of cases to allow subgroup comparisons, and potential confounding or selection biases undermine the validity of these findings.

“SARS-CoV-2 — No Increased Islet Autoimmunity or Type 1 Diabetes in Teens”

Published August 3, 2023 in The New England Journal of Medicine

In a recent twist, the latest research contradicts previous findings. Emerging data from a large prospective multinational cohort study suggest no difference in COVID-19 infection rates between pediatric patients who developed T1D during the pandemic and those who did not.

Researchers at the University of South Florida in Tampa tested over 4,500 adolescents every few months for type 1 diabetes, SARS-CoV-2 infection, and vaccination antibodies from January 2020 through December 2021. Among the 45 children diagnosed with T1D during this time, there was no statistically significant association with a history of COVID-19.

Five patients were diagnosed with diabetes before testing positive for COVID-19 nucleocapsid antibodies. One patient was diagnosed after a COVID-19 infection. Meanwhile, the other 39 children diagnosed with type 1 diabetes during the study never had a positive test for nucleocapsid antibodies. Of these, 30 were never vaccinated, two were vaccinated prior to type 1 diabetes diagnosis, four were vaccinated after the diagnosis, and three were not tested.

“COVID infections or vaccinations are not implicated in promoting type 1 diabetes in adolescents,” lead author Jeffrey Krischer, PhD, told MedPage Today.

“The increase in the number of cases seen during the pandemic was due to other factors,” Krischer explained. “It might have been the result of enhanced monitoring for the disease or more rapid clinical presentations — for example, cases that would have been diagnosed later, but were diagnosed earlier because of symptoms.”

Assessing the Results: What Can Be Determined?

While the data undeniably highlights a troubling rise in pediatric type 1 diabetes cases since the pandemic’s start, determining a causal relationship with COVID-19 remains challenging.

Experts emphasize that natural fluctuations in type 1 diabetes incidence occur over time, suggesting longer-term studies are needed to understand if the pandemic is directly responsible definitively. Additionally, some researchers note factors like increased monitoring and screening during the pandemic could lead to earlier diagnosis in some cases, potentially contributing to the observed increase.

Potential Explanations For The Trend

Diving further into potential reasons underlying the rising rates of pediatric T1D, certain studies propose that COVID-19 infection may trigger autoimmune reactions in some children that can increase their risk of developing type 1 diabetes. This theory posits that the infection may initiate or accelerate the destruction of insulin-producing cells in the pancreas. However, the evidence remains mixed, with some studies establishing clear associations between COVID-19 and subsequent type 1 diabetes and others failing to find a definitive link.

Another hypothesis suggests that reduced exposure to germs and microbes due to lockdowns and physical distancing measures may have played a role. The “hygiene hypothesis” proposes that childhood exposure to germs helps develop and regulate the immune system. With less exposure during the pandemic, some experts speculate that children may have missed out on this immune conditioning, potentially rendering them more susceptible to conditions like type 1 diabetes. Yet, concrete evidence supporting this theory remains lacking.

Further Investigation Needed 

While the existing scientific body of evidence does not establish a causal relationship between COVID-19 infection and pediatric type 1 diabetes, the concerning spike in cases among children and adolescents observed since the beginning of the pandemic warrants further scrutiny.

A more extensive research effort is needed to untangle the complex web connecting COVID-19 and the onset of type 1 diabetes in the pediatric population. The stakes are significant, as this alarming trend signals a forthcoming growing burden of life-long disease management in children. Ongoing research and vigilance will be vital to understand the reasons behind this trend and ensure that affected children have access to the best possible care.

Consequently, comprehensive and long-term investigations are critical to distinguishing the impact of the pandemic from natural fluctuations in disease incidence and to elucidate the underlying factors that contributed to this and potential other threats to pediatric health.

Key Takeaways:

  • Rates of new pediatric type 1 diabetes cases have risen significantly since the start of the COVID-19 pandemic.
  • Some theories suggest COVID-19 may trigger autoimmune reactions, or reduced immune conditioning from lockdowns could play a role.
  • The evidence implicating COVID-19 as a direct cause remains inconclusive and requires further study.
  • Longer-term monitoring of trends and underlying mechanisms is critical moving forward.
  • Regardless of the cause, providing resources and support for children with type 1 diabetes must remain a priority.

Pediatric Immune Health Summit
October 2023 Boston, MA

Pediatric Immune Health Summit 

Interested in learning more about pediatric immune health and how to leverage this critical period to ensure lifelong wellness for your patients?

Look no further than the Pediatric Immune Health Summit, where functional pediatric experts will share invaluable clinical insights and the latest evidence-based discoveries in the field to support optimal childhood development.

Click here to view more event details and save your spot today.